Literature DB >> 2482146

Association between HLA type and antibody response to malaria sporozoite and gametocyte epitopes is not evident in immune Papua New Guineans.

P M Graves1, K Bhatia, T R Burkot, M Prasad, R A Wirtz, P Beckers.   

Abstract

HLA-A,B,C and DR types were determined for 46 adults living in the Madang area of Papua New Guinea. Sera from these individuals were tested by ELISA for antibodies against: (i) sonicated schizont extract of Plasmodium falciparum; (ii) circumsporozoite repeat regions of P. falciparum and P. vivax; and (iii) epitopes on the 230 and 48/45 kD gametocyte antigens of P. falciparum. All sera were from highly immune individuals and reacted strongly to the schizont antigen. The proportions responding to circumsporozoite repeat regions were 60.7% and 23.9% for P. falciparum and P. vivax, respectively. Between 32.6 and 47.8% of adults responded to each gametocyte epitope as assessed by inhibition of monoclonal antibodies. The limited number of alleles present at each HLA locus which is characteristic of coastal Papua New Guinea was observed. Five HLA-DR alleles were detected, of which only three (HLA-DR2, 4 and w5) were present at frequencies over 0.12. All individuals possessed at least one DR2,4 or w5 allele, and 96% of individuals possessed DR2, or 4 or both. There was no evidence for association between HLA type and antibody response to circumsporozoite repeat regions or the gametocyte epitopes. Homozygotes for DR2 and 4 were able to respond to each antigen. These results imply that either there is no HLA restriction of the response to these antigens or that each DR type is responding to a different variant of the T-epitope. Even in the latter case the results are encouraging for the prospects of inclusion of an HLA-restricted T-epitope in a malaria vaccine for Papua New Guinea since a limited number of versions would be required to cover a population with an HLA profile similar to that in Madang.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482146      PMCID: PMC1534822     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.

Authors:  M F Good; D Pombo; I A Quakyi; E M Riley; R A Houghten; A Menon; D W Alling; J A Berzofsky; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein.

Authors:  M F Good; D Pombo; W L Maloy; V F de la Cruz; L H Miller; J A Berzofsky
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

3.  Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.

Authors:  W R Ballou; S L Hoffman; J A Sherwood; M R Hollingdale; F A Neva; W T Hockmeyer; D M Gordon; I Schneider; R A Wirtz; J F Young
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

4.  Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.

Authors:  L Schofield; J Villaquiran; A Ferreira; H Schellekens; R Nussenzweig; V Nussenzweig
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

Authors:  G Del Giudice; J A Cooper; J Merino; A S Verdini; A Pessi; A R Togna; H D Engers; G Corradin; P H Lambert
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

6.  Differential antibody responses to Plasmodium falciparum and P. vivax circumsporozoite proteins in a human population.

Authors:  T R Burkot; P M Graves; R A Wirtz; B J Brabin; D Battistutta; J A Cattani; R M Maizels; M P Alpers
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

7.  Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera.

Authors:  P M Graves; R Carter; T R Burkot; I A Quakyi; N Kumar
Journal:  Parasite Immunol       Date:  1988-03       Impact factor: 2.280

8.  Genetic analysis of the human malaria parasite Plasmodium falciparum.

Authors:  D Walliker; I A Quakyi; T E Wellems; T F McCutchan; A Szarfman; W T London; L M Corcoran; T R Burkot; R Carter
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

9.  Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Authors:  G Del Giudice; H D Engers; C Tougne; S S Biro; N Weiss; A S Verdini; A Pessi; A A Degremont; T A Freyvogel; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

10.  Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.

Authors:  M F Good; J A Berzofsky; W L Maloy; Y Hayashi; N Fujii; W T Hockmeyer; L H Miller
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  4 in total

1.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Lymphocyte response in vitro to Plasmodium falciparum merozoite antigens in donors from a holoendemic area.

Authors:  A Dieye; H G Heidrich; C Rogier; J F Trape; P Launois; A A Holder; J L Sarthou
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.

Authors:  Armead H Johnson; Rose G F Leke; Nancy R Mendell; Dewon Shon; Young Ju Suh; Dennis Bomba-Nkolo; Viviane Tchinda; Samuel Kouontchou; Lucy W Thuita; Anne Marie van der Wel; Alan Thomas; Anthony Stowers; Allan Saul; Ainong Zhou; Diane W Taylor; Isabella A Quakyi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.

Authors:  D J Rawlings; D C Kaslow
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.